Melodiol Issues New Shares, Maintains Transparency

Melodiol Global Health (AU:ME1) has released an update.

Melodiol Global Health Limited has issued new fully paid ordinary shares, complying with relevant sections of the Corporations Act, without the need for disclosure under Part 6D.2 of the Act. The company confirms there is no undisclosed information that would be expected in a disclosure document, ensuring transparency for investors. Melodiol focuses on high-quality cannabis and plant-based products aimed at improving the well-being of people and animals.

For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.